ArticleScientific reports2026
NucVerse3D: generalizable 3D nuclear instance segmentation across heterogeneous microscopy modalities.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Accurate three-dimensional (3D) nuclear instance segmentation is a prerequisite for quantitative phenotyping in volumetric microscopy, yet remains challenging in densely packed tissues, irregular nuclear morphologies, and across heterogeneous imaging modalities. Here we present NucVerse3D, a deep-learning framework for generalized 3D nuclei instance segmentation that combines a residual attention 3D U-Net architecture with a reversible gradient-field representation for robust centroid-aware instance reconstruction. NucVerse3D is trained end to end in 3D using modality-agnostic preprocessing and isotropic scale normalization, enabling deployment across confocal microscopy, two-photon microscopy, light-sheet microscopy, micro-computed tomography, and scanning electron microscopy volumes. We benchmarked NucVerse3D on seven volumetric datasets spanning multiple species and tissues, comprising more than forty thousand manually annotated nuclei, including newly released ground-truth datasets of mouse liver tissue (control and hepatocellular carcinoma) and Drosophila brain glial nuclei. Across datasets, NucVerse3D achieved consistently high precision and competitive recall, resulting in strong F1-scores and average precision across a wide range of imaging conditions. While a modest precision-recall imbalance is observed in certain datasets, favoring high-confidence detections, this behavior reflects a conservative instance reconstruction strategy that prioritizes accurate boundary delineation and reduces false positive segmentation in densely packed and morphologically heterogeneous tissues. A single generalized model trained on pooled data matched the performance of dataset-specific models, and ablation experiments demonstrated that preprocessing and scale normalization substantially contribute to performance under strict intersection-over-union criteria. To demonstrate the biomedical utility of NucVerse3D, we applied it to 3D liver images from a mouse model of hepatocellular carcinoma (HCC) to enable spatially resolved 3D nuclear phenotyping. In healthy liver tissue, nuclear DNA content and nuclear volume exhibited a tightly regulated log-log scaling relationship. In contrast, tumor-adjacent and tumor regions displayed progressive disruption of this coupling, forming spatially coherent domains of nuclear DNA-volume decoupling that are not detectable in conventional two-dimensional histology. We quantify this phenomenon using a Nuclear Decoupling Score (NDS), revealing increased nuclear instability aligned with pathological tissue remodeling highlighting NDS as a potential quantitative biomarker of dysplastic and tumor tissue. Together, NucVerse3D provides a robust and generalizable solution for 3D nuclear instance segmentation and enables quantitative nuclear phenotyping across imaging modalities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.